MY122829A - Linezolid-crystal form ii - Google Patents

Linezolid-crystal form ii

Info

Publication number
MY122829A
MY122829A MYPI20010371A MYPI20010371A MY122829A MY 122829 A MY122829 A MY 122829A MY PI20010371 A MYPI20010371 A MY PI20010371A MY PI20010371 A MYPI20010371 A MY PI20010371A MY 122829 A MY122829 A MY 122829A
Authority
MY
Malaysia
Prior art keywords
linezolid
crystal form
useful
antibacterial agent
known compound
Prior art date
Application number
MYPI20010371A
Other languages
English (en)
Inventor
S Bergren Michael
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY122829(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MY122829A publication Critical patent/MY122829A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MYPI20010371A 2000-02-02 2001-01-29 Linezolid-crystal form ii MY122829A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
MY122829A true MY122829A (en) 2006-05-31

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20010371A MY122829A (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Country Status (30)

Country Link
EP (1) EP1255754B1 (https=)
JP (1) JP5235256B2 (https=)
KR (3) KR20080044358A (https=)
CN (1) CN1221547C (https=)
AR (1) AR027261A1 (https=)
AT (1) ATE297920T1 (https=)
AU (1) AU782138B2 (https=)
BR (1) BR0107667A (https=)
CA (1) CA2395603C (https=)
CO (1) CO5261555A1 (https=)
CZ (1) CZ302292B6 (https=)
DE (1) DE60111497T2 (https=)
DK (1) DK1255754T3 (https=)
EA (1) EA004434B1 (https=)
EE (1) EE05197B1 (https=)
ES (1) ES2242728T3 (https=)
HU (1) HUP0301076A3 (https=)
IL (1) IL151010A0 (https=)
MX (1) MXPA02007471A (https=)
MY (1) MY122829A (https=)
NO (2) NO323459B1 (https=)
NZ (1) NZ520541A (https=)
PE (1) PE20011086A1 (https=)
PL (1) PL356433A1 (https=)
PT (1) PT1255754E (https=)
SI (1) SI1255754T1 (https=)
SK (1) SK287025B6 (https=)
TW (1) TWI297687B (https=)
WO (1) WO2001057035A1 (https=)
ZA (1) ZA200205162B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
PT1673370E (pt) 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
CA2572207A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd. Solid forms of linezolid and processes for preparation thereof
EP2174935A1 (en) * 2004-06-29 2010-04-14 Teva Pharmaceutical Industries Ltd Linezolid Compositions
EP1866295A2 (en) 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Processes for the preparation of linezolid intermediate
BRPI0605901A (pt) * 2005-06-22 2007-12-18 Teva Pharma formas polimórficas de maleato de tegaserode
DK1749517T3 (da) * 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
JP5302200B2 (ja) * 2006-10-23 2013-10-02 コンサート ファーマシューティカルズ インコーポレイテッド オキサゾリジノン誘導体および使用方法
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
JP5865898B2 (ja) 2010-04-30 2016-02-17 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ リネゾリドを調製するためのプロセス
EP2690100A1 (en) 2010-08-11 2014-01-29 Synhton B.V. Process for making linezolid
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
US20140114065A1 (en) * 2011-02-24 2014-04-24 Lee Phama Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN105461648B (zh) * 2011-05-03 2018-01-12 江苏豪森药业集团有限公司 利奈唑胺的晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
WO2013111048A1 (en) 2012-01-24 2013-08-01 Jubilant Life Sciences Limited Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
JP7101694B2 (ja) 2016-11-16 2022-07-15 ペルシカ ファーマシューティカルズ リミテッド 腰痛のための抗生物質製剤
EP3709970B1 (en) * 2017-11-16 2025-05-14 Persica Pharmaceuticals Ltd. Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
ES2166073T3 (es) * 1996-04-11 2002-04-01 Upjohn Co Procedimiento para preparar oxazolidinonas.
DK1028940T3 (da) * 1997-11-07 2007-07-30 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner

Also Published As

Publication number Publication date
CO5261555A1 (es) 2003-03-31
HUP0301076A2 (hu) 2003-08-28
KR20020072300A (ko) 2002-09-14
PE20011086A1 (es) 2001-10-04
SI1255754T1 (sl) 2005-12-31
HK1051196A1 (en) 2003-07-25
CZ20022635A3 (cs) 2002-10-16
CN1394207A (zh) 2003-01-29
TWI297687B (en) 2008-06-11
DE60111497T2 (de) 2006-05-18
CZ302292B6 (cs) 2011-02-09
NO20023654L (no) 2002-08-01
CA2395603A1 (en) 2001-08-09
CN1221547C (zh) 2005-10-05
BR0107667A (pt) 2002-10-08
NO20023654D0 (no) 2002-08-01
EA200200819A1 (ru) 2003-02-27
AU782138B2 (en) 2005-07-07
DE60111497D1 (de) 2005-07-21
PL356433A1 (en) 2004-06-28
SK287025B6 (sk) 2009-10-07
NZ520541A (en) 2004-02-27
PT1255754E (pt) 2005-11-30
SK9942002A3 (en) 2002-11-06
CA2395603C (en) 2010-03-23
EP1255754A1 (en) 2002-11-13
ES2242728T3 (es) 2005-11-16
IL151010A0 (en) 2003-02-12
ZA200205162B (en) 2003-09-29
KR20080044358A (ko) 2008-05-20
NO323459B1 (no) 2007-05-14
KR100781815B1 (ko) 2007-12-03
KR20070087178A (ko) 2007-08-27
ATE297920T1 (de) 2005-07-15
HUP0301076A3 (en) 2004-06-28
AU3275501A (en) 2001-08-14
EA004434B1 (ru) 2004-04-29
WO2001057035A1 (en) 2001-08-09
JP5235256B2 (ja) 2013-07-10
JP2003522175A (ja) 2003-07-22
EE200200420A (et) 2003-12-15
AR027261A1 (es) 2003-03-19
DK1255754T3 (da) 2005-08-22
NO20065836L (no) 2002-08-01
KR100864745B1 (ko) 2008-10-22
MXPA02007471A (es) 2002-12-13
EE05197B1 (et) 2009-08-17
EP1255754B1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
MY122829A (en) Linezolid-crystal form ii
GB0124627D0 (en) Novel compounds
UA74439C2 (uk) Сполуки спіропіразолу
MXPA02012494A (es) Tiazina oxazolidinona.
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
PL369530A1 (en) Chemical compounds
YU65802A (sh) Derivati azetidina, njihovo dobivanje i farmaceutske smeše koje ih sadrže
HK1056114A1 (zh) 血子板减少模仿剂
MXPA03009600A (es) Analogos de nociceptina.
MY129188A (en) Metalloproteinase inhibitors
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03009602A (es) Analogos de nociceptina.
SE0103710D0 (sv) Compounds
MY128164A (en) Compounds
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
UA83266C2 (en) Oxazole derivatives of tetracyclines
MXPA06000372A (es) Compuestos de silicio y su uso.
PT1268475E (pt) Novos agentes bacterianos de benzosultam-oxazolidinona
IL156331A0 (en) A process for the preparation of paclitaxel
DE60212130D1 (en) Carvedilolpolymorph
MXPA04000294A (es) Tiacin oxazolidinonas cristalinas.
AU2001287673A1 (en) Novel trioxepan compounds
WO2001055198A3 (de) Haut- und magen-spezifischer sphingolipid-aktivator
ECSP003746A (es) Oxazolidinonas derivadas de sultamas y sultonas